An Open Label Clinical Pilot Study of Resveratrol as a Treatment for Friedreich Ataxia

An Open Label Clinical Pilot Study of Resveratrol as a Treatment for Friedreich Ataxia 13th Asian Oceanian Congress of Neurology, 4–8 June 2012, Melbourne Convention and Exhibition Centre, Melbourne, Australia
Keywords: Friedreich ataxia (FRDA), mitochondrial protein frataxin, Resveratrol, anti-oxidant, neuroprotective, open-label sequential clinical pilot study, lymphocyte frataxin levels.